Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study

Observational studies have suggested a protective role for eosinophils in colorectal cancer (CRC) development and implicated neutrophils, but the causal relationships remain unclear. Here, we aimed to estimate the causal effect of circulating white blood cell (WBC) counts (N = ~550 000) for basophils, eosinophils, monocytes, lymphocytes and neutrophils on CRC risk (N = 52 775 cases and 45 940 controls) using Mendelian randomisation (MR). For comparison, we also examined this relationship using individual‐level data from UK Biobank (4043 incident CRC cases and 332 773 controls) in a longitudinal cohort analysis. The inverse‐variance weighted (IVW) MR analysis suggested a protective effect of increased basophil count and eosinophil count on CRC risk [OR per 1‐SD increase: 0.88, 95% CI: 0.78‐0.99, P = .04; OR: 0.93, 95% CI: 0.88‐0.98, P = .01]. The protective effect of eosinophils remained [OR per 1‐SD increase: 0.88, 95% CI: 0.80‐0.97, P = .01] following adjustments for all other WBC subtypes, to account for genetic correlation between the traits, using multivariable MR. A protective effect of increased lymphocyte count on CRC risk was also found [OR: 0.84, 95% CI: 0.76‐0.93, P = 6.70e‐4] following adjustment. Consistent with MR results, a protective effect for eosinophils in the cohort analysis in the fully adjusted model [RR per 1‐SD increase: 0.96, 95% CI: 0.93‐0.99, P = .02] and following adjustment for the other WBC subtypes [RR: 0.96, 95% CI: 0.93‐0.99, P = .001] was observed. Our study implicates peripheral blood immune cells, in particular eosinophils and lymphocytes, in CRC development, highlighting a need for mechanistic studies to interrogate these relationships.

[1]  A. Munitz,et al.  Changes in peripheral blood eosinophils may predict colorectal cancer – A retrospective study , 2022, The World Allergy Organization journal.

[2]  P. Kubes,et al.  Neutrophil phenotypes and functions in cancer: A consensus statement , 2022, The Journal of experimental medicine.

[3]  N. Timpson,et al.  Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration , 2021, BMJ.

[4]  K. Obama,et al.  Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients , 2021, International journal of molecular sciences.

[5]  Pengfei Xu,et al.  Global colorectal cancer burden in 2020 and projections to 2040 , 2021, Translational oncology.

[6]  N. Galwey,et al.  Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis , 2021, European Respiratory Journal.

[7]  B. Becher,et al.  The GM-CSF–IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses , 2020, The Journal of experimental medicine.

[8]  H. Sallis,et al.  Let's call it the effect allele: a suggestion for GWAS naming conventions. , 2020, International journal of epidemiology.

[9]  T. Key,et al.  Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[10]  J. Bowden,et al.  Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization , 2020, bioRxiv.

[11]  A. Williams,et al.  Demographic trends in the incidence of young‐onset colorectal cancer: a population‐based study , 2020, The British journal of surgery.

[12]  S. Gruber,et al.  The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis , 2020, Scientific Reports.

[13]  Xinxiang Li,et al.  Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer , 2020, Clinical and Translational Medicine.

[14]  M. Hull Nutritional prevention of colorectal cancer , 2020, Proceedings of the Nutrition Society.

[15]  William J. Astle,et al.  Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations , 2020, Cell.

[16]  P. Elliott,et al.  White Blood Cell Count and Risk of Incident Lung Cancer in the UK Biobank. , 2019, JNCI cancer spectrum.

[17]  George Davey Smith,et al.  Guidelines for performing Mendelian randomization investigations: update for summer 2023 , 2019, Wellcome open research.

[18]  G. Smith,et al.  Mendelian randomisation for mediation analysis: current methods and challenges for implementation , 2019, bioRxiv.

[19]  J. Ferlay,et al.  Changes in colorectal cancer incidence in seven high-income countries: a population-based study. , 2019, The lancet. Gastroenterology & hepatology.

[20]  Joseph H. Marcus,et al.  Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics , 2019, bioRxiv.

[21]  A. Jemal,et al.  Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. , 2019, The Lancet. Public health.

[22]  Huy Q. Dinh,et al.  Monocyte heterogeneity and functions in cancer , 2019, Journal of leukocyte biology.

[23]  R. Gerth van Wijk,et al.  The association between allergic diseases and cancer: a systematic review of the literature. , 2019, The Netherlands journal of medicine.

[24]  Wenyu Zhu,et al.  Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. , 2019, Molecular medicine reports.

[25]  A. Bardelli,et al.  Early‐onset colorectal cancer in young individuals , 2018, Molecular oncology.

[26]  Y. Fujiwara,et al.  A prognostic index for colorectal cancer based on preoperative absolute lymphocyte, monocyte, and neutrophil counts , 2018, Surgery Today.

[27]  Stephanie A. Bien,et al.  Discovery of common and rare genetic risk variants for colorectal cancer , 2018, Nature Genetics.

[28]  Yisheng Wei,et al.  The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer , 2018, Asia-Pacific journal of clinical oncology.

[29]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[30]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[31]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[32]  F. Windmeijer,et al.  An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings , 2018, bioRxiv.

[33]  B. Neale,et al.  Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.

[34]  G. Marone,et al.  Eosinophils: The unsung heroes in cancer? , 2018, Oncoimmunology.

[35]  G. Davey Smith,et al.  Orienting the causal relationship between imprecisely measured traits using GWAS summary data , 2017, PLoS genetics.

[36]  Jianting Cai,et al.  Association between allergic conditions and colorectal cancer risk/mortality: a meta-analysis of prospective studies , 2017, Scientific Reports.

[37]  Fernando Pires Hartwig,et al.  Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.

[38]  S. Narod,et al.  Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records , 2017, British Journal of Cancer.

[39]  James R. Staley,et al.  The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease , 2016, Cell.

[40]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[41]  W. Hwang,et al.  A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results , 2016, Digestive Diseases and Sciences.

[42]  J. Cerhan,et al.  Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women’s Health Study , 2016, Modern Pathology.

[43]  Stephen Burgess,et al.  Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.

[44]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[45]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[46]  Kutlu G. Elpek,et al.  IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses. , 2015, Cell reports.

[47]  D. Nickerson,et al.  A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians , 2014, bioRxiv.

[48]  G. Davey Smith,et al.  Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.

[49]  Yan Guo,et al.  Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk , 2014, Nature Genetics.

[50]  A. Folsom,et al.  Inverse Association of Eosinophil Count with Colorectal Cancer Incidence: Atherosclerosis Risk in Communities Study , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[51]  S. Thompson,et al.  Bias in causal estimates from Mendelian randomization studies with weak instruments , 2011, Statistics in medicine.

[52]  D. Dombrowicz,et al.  Human Eosinophils Exert TNF-α and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma Cells , 2010, The Journal of Immunology.

[53]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[54]  T. Gunji,et al.  Number of Eosinophils and Incidence of Cancer in a Japanese Population : A Single Institution Study , 2019 .

[55]  M. Eaman Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).